Search Results - Netterberg, Ida
- Showing 1 - 5 results of 5
-
1
-
2
The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin‐6 and C‐reactive protein by modelling by Netterberg, Ida, Karlsson, Mats O., Nielsen, Elisabet I., Quartino, Angelica L., Lindman, Henrik, Friberg, Lena E.
Published 2018Text -
3
Tumor Time‐Course Predicts Overall Survival in Non‐Small Cell Lung Cancer Patients Treated with Atezolizumab: Dependency on Follow‐Up Time by Netterberg, Ida, Bruno, René, Chen, Ya‐Chi, Winter, Helen, Li, Chi‐Chung, Jin, Jin Y., Friberg, Lena E.
Published 2020Text -
4
A PK/PD Analysis of Circulating Biomarkers and Their Relationship to Tumor Response in Atezolizumab‐Treated non‐small Cell Lung Cancer Patients by Netterberg, Ida, Li, Chi‐Chung, Molinero, Luciana, Budha, Nageshwar, Sukumaran, Siddharth, Stroh, Mark, Jonsson, E. Niclas, Friberg, Lena E.
Published 2018Text -
5
Risk Factors for Development of Cholestatic Drug-Induced Liver Injury: Inhibition of Hepatic Basolateral Bile Acid Transporters Multidrug Resistance-Associated Proteins 3 and 4 by Köck, Kathleen, Ferslew, Brian C., Netterberg, Ida, Yang, Kyunghee, Urban, Thomas J., Swaan, Peter W., Stewart, Paul W., Brouwer, Kim L. R.
Published 2014Text